Showing posts with label Erlotinib (structure) plus bevacizumab promising. Show all posts
Showing posts with label Erlotinib (structure) plus bevacizumab promising. Show all posts
Thursday, December 10, 2015

Early trial results in lung cancer

›
Results from early phase trials investigating different therapeutic agents in lung cancer patients were presented during the third Pr...